Safety of Oral Dofetilide for Rhythm Control of Atrial Fibrillation and Atrial Flutter

Circulation: Arrhythmia and Electrophysiology

Volumn 8, Issue 4, 2015, Pages 772-776

  Abraham, Joellyn M ^a   Saliba, Walid I ^b   Vekstein, Carolyn ^c   Lawrence, David ^d   Bhargava, Mandeep ^b   Bassiouny, Mohamed ^b   Janiszewski, David ^b   Lindsay, Bruce ^b   Militello, Michael ^b   Nissen, Steven E ^b   Poe, Stacy ^b   Tanaka Esposito, Christine ^b   Wolski, Kathy ^b   Wilkoff, Bruce L ^b  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c BROWN UNIVERSITY   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

anti arrhythmic drugs; atrial fibrillation; atrial flutter; dofetilide; Torsade de pointes

Indexed keywords

DOFETILIDE; ANTIARRHYTHMIC AGENT; PHENETHYLAMINE DERIVATIVE; SULFONAMIDE;

AGED; AORTA STENOSIS; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR MORTALITY; COMPARATIVE STUDY; DRUG COST; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; FAINTNESS; FEMALE; HEADACHE; HEART AMYLOIDOSIS; HEART ARREST; HEART ATRIUM FLUTTER; HEART EJECTION FRACTION; HEART RHYTHM; HUMAN; INTESTINE ISCHEMIA; KIDNEY FAILURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT MONITORING; PRIORITY JOURNAL; RESUSCITATION; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SINUS NODE DISEASE; SUPRAVENTRICULAR TACHYCARDIA; TORSADE DES POINTES; TRANSIENT ISCHEMIC ATTACK; ATRIAL FLUTTER; CAUSE OF DEATH; DOSE RESPONSE; DRUG EFFECTS; ELECTROCARDIOGRAPHY; EPIDEMIOLOGY; FOLLOW UP; HEART RATE; MORTALITY; PATHOPHYSIOLOGY; TREATMENT OUTCOME; TRENDS; UNITED STATES;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CAUSE OF DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; OHIO; PHENETHYLAMINES; RETROSPECTIVE STUDIES; SULFONAMIDES; TREATMENT OUTCOME;

EID: 84939780752     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.114.002339     Document Type: Article

References (12)

1. Yang T, Chun YW, Stroud DM, Mosley JD, Knollmann BC, Hong C, Roden DM. Screening for acute IKr block is insufficient to detect torsades de pointes liability: role of late sodium current. Circulation. 2014; 130: 224-234. doi: 10. 1161/CIRCULATIONAHA. 113. 007765.
2. Pedersen OD, Bagger H, Keller N, Marchant B, Køber L, Torp-Pedersen C. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: A Danish investigations of arrhythmia and mortality on dofetilide (DIAMOND) substudy. Circulation. 2001; 104: 292-296.
3. Torp-Pedersen C, Møller M, Bloch-Thomsen PE, Køber L, Sandøe E, Egstrup K, Agner E, Carlsen J, Videbaek J, Marchant B, Camm AJ. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med. 1999; 341: 857-865. doi: 10. 1056/ NEJM199909163411201.
4. Køber L, Bloch Thomsen PE, Møller M, Torp-Pedersen C, Carlsen J, Sandøe E, Egstrup K, Agner E, Videbaek J, Marchant B, Camm AJ; Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group. Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: A randomised trial. Lancet. 2000; 356: 2052-2058.
5. Singh S, Zoble RG, Yellen L, Brodsky MA, Feld GK, Berk M, Billing CB Jr. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: The symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation. 2000; 102: 2385-2390.
6. Campbell TJ, Greenbaum RA, Channer KS, Dairymple HW, Kingma JH, Santini M, Theisen K, Toivonen K. Mortality in patients with atrial fibrillation-1 year follow-up of EMERALD (European and Australian multicenter evaluative research on atrial fibrillation dofetilide). J Am Coll Cardiol. 2000; 35: 154A-155A.
7. Greenbaum R, Campbell TJ, Channer KS, Dairymple HW, Kingma JH, Santini M, Theisen K, Tolvonnen LK. Conversion of atrial fibrillaton and maintenance of sinus rhythm by dofetilide: The emerald (European and Australian multicenter evaluative research on atrial fibrillation dofetilide) study. Circulation. 1998; 98: I 633.
8. Lawrence D, Abraham JM, Saliba W, Bhargava M, Militello M, Niebauer M, Poe S, Vekstein C, Wilkoff B. Dofetilide long-term efficacy despite inability to convert to sinus rhythm during admission for drug initiation. J Am Coll Cardiol. 2014; 63: A421.
9. Gordon M. Dofetilide medical review. http: //www. accessdata. fda. gov/ drugsatfda-docs/nda/99/20-931-Tikosyn. cfm. 1999; Accessed February 24, 2012.
10. Pedersen HS, Elming H, Seibaek M, Burchardt H, Brendorp B, Torp-Pedersen C, Køber L; DIAMOND Study Group. Risk factors and predictors of Torsade de pointes ventricular tachycardia in patients with left ventricular systolic dysfunction receiving Dofetilide. Am J Cardiol. 2007; 100: 876-880. doi: 10. 1016/j. amjcard. 2007. 04. 020.
11. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW; ACC/AHA Task Force Members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014; 130: 2071-2104. doi: 10. 1161/CIR. 0000000000000040.
12. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002; 347: 1825-1833. doi: 10. 1056/ NEJMoa021328.